Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Mir A. ImranDirector | Rani Therapeutics HoldingsRANI | Open-market buy | 25/10/23 | 25/10/27 | 2,083,334 sh | $0.61 | $1,270,833.74 | No record |
Rani Therapeutics HoldingsRANI | Open-market sale | 25/10/20–25/10/21 | 25/10/22 | 5,923,000 sh2 trades | $2.65avg. | $15,714,430 | −71.3% | |
Kate McKinleyChief Business Officer | Rani Therapeutics HoldingsRANI | Open-market buy | 24/12/13 | 24/12/16 | 17,960 sh | $1.67 | $29,993.2 | No record |
Talat ImranCEO | Rani Therapeutics HoldingsRANI | Open-market buy | 24/12/09 | 24/12/10 | 10,296 sh | $1.94 | $19,974.24 | +2.1% |
Rani Therapeutics HoldingsRANI | Open-market sale | 24/10/15 | 24/10/17 | 3,829,360 sh2 trades | $2.65avg. | $10,136,721.98 | −31.6% | |
Rani Therapeutics HoldingsRANI | Open-market sale | 24/10/15 | 24/10/17 | 3,829,360 sh2 trades | $2.65avg. | $10,136,721.98 | −31.6% | |
South Lake One10% Owner | Rani Therapeutics HoldingsRANI | Open-market buy | 23/11/24 | 23/12/08 | 5,265,165 sh | $2.01 | $10,582,981.65 | +76.7% |
Cortes Isidoro Alfonso Quiroga10% Owner | Rani Therapeutics HoldingsRANI | Open-market sale | 23/11/24 | 23/12/08 | 5,265,165 sh | $2.01 | $10,582,981.65 | −99.8% |
Rani Therapeutics HoldingsRANI | Open-market buy | 23/11/24 | 23/12/08 | 5,265,165 sh | $2.01 | $10,582,981.65 | +76.7% | |
Aequanimitas Limited Partnership10% Owner | Rani Therapeutics HoldingsRANI | Open-market sale | 23/11/24 | 23/12/08 | 5,265,165 sh | $2.01 | $10,582,981.65 | −99.8% |
Talat ImranCEO | Rani Therapeutics HoldingsRANI | Open-market buy | 23/12/06 | 23/12/07 | 10,000 sh | $2.27 | $22,700 | +2.1% |
Talat ImranCEO | Rani Therapeutics HoldingsRANI | Open-market buy | 23/12/04 | 23/12/06 | 5,000 sh | $2.57 | $12,850 | +1.1% |
Talat ImranCEO | Rani Therapeutics HoldingsRANI | Open-market buy | 23/11/29 | 23/12/01 | 20,000 sh | $2.05 | $41,000 | +4.4% |
Jean Luc ButelDirector | Rani Therapeutics HoldingsRANI | Open-market buy | 23/11/17 | 23/11/21 | 50,500 sh | $2.03 | $102,515 | No record |
Maulik NanavatyDirector | Rani Therapeutics HoldingsRANI | Open-market buy | 23/11/16 | 23/11/20 | 500 sh | $1.98 | $990 | No record |
Rani Therapeutics HoldingsRANI | Open-market buy | 23/11/07 | 23/11/09 | 5,000 sh2 trades | $2.00avg. | $9,975 | +1.1% | |
Rani Therapeutics HoldingsRANI | Open-market buy | 23/05/11–23/05/12 | 23/05/15 | 5,255 sh2 trades | $3.93avg. | $20,627.8 | +0.1% | |
Rani Therapeutics HoldingsRANI | Open-market buy | 23/05/11–23/05/12 | 23/05/15 | 5,255 sh2 trades | $3.93avg. | $20,627.8 | +0.1% | |
South Lake One10% Owner | Rani Therapeutics HoldingsRANI | Open-market buy | 23/05/08 | 23/05/10 | 4,420 sh | $4.46 | $19,713.2 | +0.1% |
Rani Therapeutics HoldingsRANI | Open-market buy | 23/05/08 | 23/05/10 | 4,420 sh | $4.46 | $19,713.2 | +0.1% |